To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RASEFTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
113 supporting clones for gene RASEF back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BE207066 lung, small cell carcinoma .a 1 to 557 16 to 572   tiling clone,   557/572
(97 %)
6 diff
(99.0 %id)
BC023566 Muscle, rhabdomyosarcoma .a 11 to 2762 1 to 2752   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 2752/2752
(100 %)
0 diff
(100 %id)
NM_152573.2   .a 11 to 2762 1 to 2752   RefSeq, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 2752/2752
(100 %)
0 diff
(100 %id)
DR005276 Prostate .a 262 to 843 8 to 589       582/589
(98 %)
6 diff
(99.0 %id)
AK290986   .a 269 to 2565 1 to 2297       2297/2297
(100 %)
3 diff
(99.9 %id)
DC368081   .a 269 to 819 1 to 559       559/559
(100 %)
8 diff
(98.6 %id)
BX509641   .a 566 to 1105 1 to 541       541/541
(100 %)
1 diff
(99.9 %id)
BF950590 nervous_normal .a 679 to 941 277 to 16       262/277
(94 %)
0 diff
(100 %id)
BX484987   .a 844 to 1325 1 to 482       482/482
(100 %)
6 diff
(98.8 %id)
BU944143 adenocarcinoma, cell line, breast .a 958 to 1916 16 to 977       962/984
(97 %)
15 diff
(98.5 %id)
BU859847 adenocarcinoma, cell line, breast .a 966 to 1830 1 to 874       874/876
(99 %)
11 diff
(98.8 %id)
AA470519   .a 1406 to 1776 1 to 371       371/371
(100 %)
6 diff
(98.4 %id)
BG334589 melanotic melanoma, skin .a 1414 to 2172 1 to 751       751/927
(81 %)
24 diff
(97.5 %id)
BE302954 melanotic melanoma, skin .a 1416 to 1829 1 to 414       414/414
(100 %)
0 diff
(100 %id)
BE303010 melanotic melanoma, skin .a 1416 to 1788 1 to 373       373/373
(100 %)
0 diff
(100 %id)
BE384120 melanotic melanoma, skin .a 1435 to 1995 1 to 561       561/562
(99 %)
4 diff
(99.3 %id)
CB986599 Pooled-Glandular .a 1489 to 2180 1 to 697       697/919
(75 %)
19 diff
(98.0 %id)
BU102123   .a 1877 to 2395 519 to 1       519/519
(100 %)
0 diff
(100 %id)
BX479058   .a 1925 to 2604 1 to 678       678/678
(100 %)
3 diff
(99.6 %id)
DA461089 tongue, tumor tissue .a 1972 to 2533 2 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
EC499860 Prostate .a 2063 to 2151 89 to 1       89/89
(100 %)
0 diff
(100 %id)
R78655 placenta .a 2169 to 2763 1 to 589   fully sequenced,   589/589
(100 %)
23 diff
(96.1 %id)
BE300686 melanotic melanoma, skin .a 2171 to 2766 596 to 1       596/596
(100 %)
5 diff
(99.2 %id)
BX103248 placenta .a 2172 to 2762 1 to 591   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 591/591
(100 %)
0 diff
(100 %id)
AW615433 lung, small cell carcinoma .a 2204 to 2767 564 to 1       564/564
(100 %)
1 diff
(99.9 %id)
AA601537 breast .a 2305 to 2762 458 to 1       458/458
(100 %)
0 diff
(100 %id)
TI_153991278   .a 2311 to 2762 542 to 91   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 452/459
(98 %)
13 diff
(97.2 %id)
AA534917 colon .a 2315 to 2762 449 to 1       449/496
(90 %)
5 diff
(99.0 %id)
AA480404 Liver .a 2380 to 2678 1 to 299       299/299
(100 %)
6 diff
(98.0 %id)
AA470565   .a 2403 to 2763 361 to 1       361/361
(100 %)
0 diff
(100 %id)
AI446047 adenocarcinoma, Pancreas .a 2448 to 2762 344 to 30   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 315/315
(100 %)
10 diff
(96.9 %id)
AW182013 pooled .a 2452 to 2763 311 to 1       311/315
(98 %)
4 diff
(98.8 %id)
AI738861 ovary, tumor, 5 pooled (see description) .a 2471 to 2755 286 to 1       286/286
(100 %)
1 diff
(99.7 %id)
AI915961 Kidney .a 2475 to 2762 288 to 1       288/288
(100 %)
0 diff
(100 %id)
R78618 placenta .a 2514 to 2746 241 to 1   fully sequenced,   241/241
(100 %)
0 diff
(100 %id)
AI498405 Kidney .a 2531 to 2771 430 to 190   AAA   241/430
(56 %)
0 diff
(100 %id)
AW873267 normal epithelium, thyroid .a 2555 to 2762 257 to 50   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 208/215
(96 %)
6 diff
(97.3 %id)
BX099582 carcinoid, lung .a 2644 to 3119 1 to 476       476/476
(100 %)
4 diff
(99.2 %id)
DA045059 bladder .a 2730 to 3299 2 to 571   capped   570/570
(100 %)
5 diff
(99.2 %id)
AK056882 Prostate .a 2735 to 5581 1 to 2847   tiling clone, available from FLJ,   2847/2847
(100 %)
2 diff
(100.0 %id)
DA868279 Prostate .a 2736 to 3317 2 to 582   capped   581/581
(100 %)
1 diff
(99.9 %id)
DB207187 trachea .a 3088 to 3586 2 to 501   capped   500/500
(100 %)
1 diff
(99.8 %id)
AI298493 carcinoid, lung .a 3178 to 3569 392 to 1       392/392
(100 %)
8 diff
(98.0 %id)
AW205358   .a 3180 to 3566 403 to 17   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 387/387
(100 %)
3 diff
(99.3 %id)
AA976604 carcinoid, lung .a 3191 to 3567 377 to 1       377/377
(100 %)
0 diff
(100 %id)
BM786593 Ascites, stomach .a 3263 to 3852 1 to 590       590/590
(100 %)
1 diff
(99.9 %id)
BQ352741 head_neck .a 3370 to 3680 313 to 2       312/318
(98 %)
0 diff
(100 %id)
BQ229028 melanotic melanoma, skin .a 3641 to 4485 1 to 858       858/887
(96 %)
25 diff
(97.2 %id)
CN290188 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3665 to 4432 1 to 768       768/768
(100 %)
8 diff
(99.0 %id)
CB122075 Liver .a 3730 to 4068 1 to 338       338/338
(100 %)
3 diff
(99.2 %id)
BQ439461 melanotic melanoma, skin .a 3760 to 4501 1 to 747       747/909
(82 %)
21 diff
(97.7 %id)
TI_57145958   .a 3765 to 4511 62 to 805       744/809
(91 %)
10 diff
(98.8 %id)
BI759135 pooled colon, kidney, stomach .a 3768 to 4511 1 to 742       742/746
(99 %)
10 diff
(98.7 %id)
AI547059 Prostate .a 3789 to 4450 13 to 665       653/824
(79 %)
48 diff
(94.2 %id)
FN058233 breast carcinoma .a 3814 to 3867 1 to 54       54/55
(98 %)
1 diff
(98.2 %id)
FN093069 breast carcinoma .a 3966 to 4082 118 to 1     Submitted on the opposite strand 118/119
(99 %)
2 diff
(98.4 %id)
CB113169 Liver .a 4042 to 4663 1 to 623       623/623
(100 %)
3 diff
(99.6 %id)
FN084890 breast carcinoma .a 4049 to 4120 1 to 74       74/81
(91 %)
7 diff
(91.4 %id)
FN100590 breast carcinoma .a 4077 to 4194 1 to 116       116/116
(100 %)
6 diff
(94.9 %id)
DN914144   .a 4098 to 4773 1 to 676       676/676
(100 %)
3 diff
(99.6 %id)
FN120907 breast carcinoma .a 4110 to 4219 1 to 107       107/108
(99 %)
4 diff
(96.3 %id)
FN171826 breast carcinoma .a 4266 to 4364 99 to 1     Submitted on the opposite strand 99/103
(96 %)
1 diff
(99.1 %id)
FN140176 breast carcinoma .a 4472 to 4557 86 to 1     Submitted on the opposite strand 86/95
(90 %)
0 diff
(100 %id)
FN117995 breast carcinoma .a 4536 to 4648 1 to 112       112/112
(100 %)
1 diff
(99.2 %id)
BM748279 Ascites, stomach .a 4574 to 5120 1 to 548       548/548
(100 %)
12 diff
(97.9 %id)
BM758077 Ascites, stomach .a 4574 to 5119 1 to 540       540/540
(100 %)
7 diff
(98.8 %id)
BM748515 Ascites, stomach .a 4575 to 5187 1 to 607       607/607
(100 %)
8 diff
(98.7 %id)
BF208992 bladder, carcinoma, cell line .a 4617 to 5155 1 to 536       536/537
(99 %)
7 diff
(98.7 %id)
BE568426 bladder, carcinoma, cell line .a 4637 to 5235 1 to 581       581/851
(68 %)
9 diff
(99.0 %id)
FN062972 breast carcinoma .a 4766 to 4829 65 to 3     Submitted on the opposite strand 63/66
(95 %)
0 diff
(100 %id)
FN112728 breast carcinoma .a 4769 to 4867 99 to 1     Submitted on the opposite strand 99/99
(100 %)
0 diff
(100 %id)
BE928360 colon .a 4773 to 5153 1 to 382       382/382
(100 %)
9 diff
(97.7 %id)
FN137741 breast carcinoma .a 4808 to 4913 107 to 1     Submitted on the opposite strand 107/107
(100 %)
1 diff
(99.1 %id)
FN167755 breast carcinoma .a 4810 to 4913 104 to 1     Submitted on the opposite strand 104/107
(97 %)
2 diff
(98.2 %id)
TI_149297213   .a 4820 to 5586 854 to 94   tiling clone, AAA   761/935
(81 %)
11 diff
(98.9 %id)
BM982321 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 4890 to 5586 715 to 19   AAA   697/697
(100 %)
0 diff
(100 %id)
AI890787 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 4891 to 5300 410 to 1       410/410
(100 %)
0 diff
(100 %id)
BF691828 melanotic melanoma, high MDR, skin .a 4954 to 5581 1 to 628   AAA   628/628
(100 %)
2 diff
(99.7 %id)
BM856433 stomach .a 4977 to 5512 1 to 536       536/536
(100 %)
0 diff
(100 %id)
DN914145   .a 5000 to 5580 581 to 1       581/581
(100 %)
3 diff
(99.5 %id)
DB314551 tongue, tumor tissue .a 5020 to 5580 561 to 1       561/561
(100 %)
1 diff
(99.9 %id)
DB329754 Prostate .a 5051 to 5581 531 to 1       531/531
(100 %)
2 diff
(99.7 %id)
C06338   .a 5057 to 5581 546 to 9       538/638
(84 %)
0 diff
(100 %id)
BE463583 Kidney .a 5077 to 5579 503 to 1       503/503
(100 %)
0 diff
(100 %id)
TI_149271348   .a 5077 to 5579 590 to 87   AAA   504/925
(54 %)
19 diff
(98.0 %id)
AA826324 colon, colon tumor .a 5169 to 5581 449 to 37   AAA   413/413
(100 %)
0 diff
(100 %id)
AA622862 germ cell tumor .a 5178 to 5580 405 to 3       403/405
(99 %)
0 diff
(100 %id)
AA775044 lung .a 5233 to 5580 348 to 1       348/348
(100 %)
0 diff
(100 %id)
BU674359 lung, Primary Lung Epithelial Cells .a 5235 to 5579 363 to 19   AAA   345/345
(100 %)
2 diff
(99.5 %id)
AA621523   .a 5283 to 5581 299 to 1       299/299
(100 %)
1 diff
(99.7 %id)
FN171200 breast carcinoma .a 5287 to 5379 1 to 93       93/93
(100 %)
4 diff
(95.7 %id)
FN123177 breast carcinoma .a 5336 to 5407 74 to 5     Submitted on the opposite strand 70/75
(93 %)
0 diff
(100 %id)
BF036636 adenocarcinoma, ovary .a 5423 to 5521 101 to 3     Submitted on the opposite strand 99/156
(63 %)
0 diff
(100 %id)
AW873470 normal epithelium, thyroid .a 5456 to 5579 143 to 20   AAA   124/124
(100 %)
0 diff
(100 %id)
FN127241 breast carcinoma .a 5512 to 5580 1 to 68       68/72
(94 %)
2 diff
(97.3 %id)
AK056176   .b 1 to 1765 2 to 1766   tiling clone, available from FLJ,   1766/1766
(100 %)
2 diff
(99.9 %id)
DA700534   .b 1 to 522 2 to 523   capped   522/522
(100 %)
0 diff
(100 %id)
BG574207 breast, mammary adenocarcinoma, cell line .b 48 to 705 1 to 658       658/658
(100 %)
0 diff
(100 %id)
BF204000 muscle, rhabdomyosarcoma .b 49 to 651 1 to 595       595/820
(72 %)
20 diff
(97.6 %id)
BF309896 muscle, rhabdomyosarcoma .b 49 to 748 1 to 701       701/819
(85 %)
21 diff
(97.5 %id)
BF305622 muscle, rhabdomyosarcoma .b 49 to 644 1 to 595       595/595
(100 %)
8 diff
(98.7 %id)
BE296035 muscle, rhabdomyosarcoma .b 69 to 737 1 to 700       700/766
(91 %)
21 diff
(97.3 %id)
C75633   .b 410 to 721 10 to 319       310/319
(97 %)
6 diff
(98.2 %id)
C75455   .b 415 to 963 1 to 534       534/549
(97 %)
21 diff
(96.2 %id)
C75612   .b 415 to 827 1 to 412       412/414
(99 %)
6 diff
(98.6 %id)
DN996468 breast cancer, Mammary gland (cancer tissue) .c 1 to 646 1 to 644 exact tiling clone,   644/644
(100 %)
5 diff
(99.3 %id)
BX497517 Liver .d-u 1 to 544 1 to 538   tiling clone,   538/538
(100 %)
8 diff
(98.6 %id)
CB160663 Liver .d-u 113 to 743 1 to 627 L38V C39S S41Y S43C S45R ... tiling clone,   627/627
(100 %)
8 diff
(98.8 %id)
AW071061 breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary .d-u 494 to 924 429 to 3   tiling clone,   427/429
(99 %)
0 diff
(100 %id)
BE710045 head_neck Gene RASEF, variant not shown         Suspected internal deletion, this clone was ignored    
BE710046 head_neck Gene RASEF, variant not shown         Suspected internal deletion, this clone was ignored    
AI632964 carcinoid, lung Gene RASEF, variant not shown         This clone was ignored    
BE566444 bladder, carcinoma, cell line Gene RASEF, variant not shown         This clone was ignored    
BF029268 bladder, carcinoma, cell line Gene RASEF, variant not shown         This clone was ignored    
BF541607 hypernephroma, Kidney Gene RASEF, variant not shown         This clone was ignored    
BF207929 bladder, carcinoma, cell line Gene RASEF, variant not shown         Suspected internal deletion, this clone was ignored    
BQ439756 melanotic melanoma, skin Gene RASEF, variant not shown         This clone was ignored    
BM743380 Ascites, stomach Gene RASEF, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC